Synthetic Blood Substitutes And Blood Products Global Market Report 2025

Description

Synthetic blood substitutes and blood products are innovative medical solutions designed to replicate the functions of human blood, such as oxygen transport and clotting, to assist patients in need of blood transfusions. Developed through biotechnological processes, these products play a vital role in addressing blood shortages and offering alternatives for emergencies or individuals with specific medical conditions.

The primary categories of synthetic blood substitutes and blood products include perfluorocarbon-based products (PFCs), hemoglobin-based oxygen carriers, synthetic platelets, recombinant factors, and blood expanders. Perfluorocarbon-based products (PFCs) function as synthetic oxygen carriers capable of dissolving and transporting oxygen and carbon dioxide within the bloodstream, serving as blood substitutes in medical treatments. These products are utilized for various purposes, including the treatment of cardiovascular diseases, anemia, organ transplants, injuries, and trauma. Additionally, they are used by multiple end users, such as hospitals and clinics, blood banks, and other medical institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The synthetic blood substitutes and blood products market research report is one of a series of new reports from The Business Research Company that provides synthetic blood substitutes and blood products market statistics, including the synthetic blood substitutes and blood products industry global market size, regional shares, competitors with the synthetic blood substitutes and blood products market share, detailed synthetic blood substitutes and blood products market segments, market trends, and opportunities, and any further data you may need to thrive in the synthetic blood substitutes and blood products industry. This synthetic blood substitutes and blood products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The synthetic blood substitutes and blood products market size has grown rapidly in recent years. It will grow from $6.55 billion in 2024 to $7.6 billion in 2025 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to an aging population, increasing demand for blood transfusions, rising demand for safe and contaminant-free blood, growing awareness of blood transfusion risks, and increased focus on emergency medical care.

The synthetic blood substitutes and blood products market size is expected to see rapid growth in the next few years. It will grow to $13.63 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to expanding applications in military and disaster response, increasing awareness of alternative blood substitutes, growing prevalence of blood-related disorders, and rising incidence of trauma and emergency surgeries. Major trends in the forecast period include the development of hemoglobin-based oxygen carriers, regulatory approvals and research, advancements in biotechnology, regenerative medicine advancements, and the integration of artificial intelligence (AI).

The forecast of 15.7% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for hemoglobin-based oxygen carriers and sterile filtration systems, sourced from key regions such as the United Kingdom and Denmark, could lead to treatment limitations and higher transfusion alternative costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases is expected to drive the growth of the synthetic blood substitutes and blood products market in the coming years. Chronic diseases are long-term conditions that require ongoing medical attention and can often be managed but not cured. Several factors contribute to the rising prevalence of these conditions, including an aging population, unhealthy lifestyles, and increased life expectancy. Synthetic blood substitutes and blood products play a crucial role in managing chronic diseases by addressing challenges related to blood loss, anemia, and organ function, which are common among affected patients. For example, in June 2024, the Australian Institute of Health and Welfare reported that deaths due to chronic conditions in Australia increased from 459 deaths per 100,000 population in 2021 to 490 in 2022. This growing burden of chronic diseases is driving the demand for synthetic blood substitutes and blood products.

Companies in the synthetic blood substitutes and blood products market are focusing on innovations such as lab-grown blood vessels to improve emergency medical care, enhance trauma treatment, and address shortages of donor blood and tissues. Lab-grown blood vessels, engineered from human or synthetic cells, mimic the structure and function of natural arteries and veins, making them valuable for applications such as trauma repair, dialysis, and cardiovascular surgery. For instance, in December 2024, Humacyte Global, Inc., a US-based clinical-stage biotechnology company, received FDA approval for Symvess, an off-the-shelf bioengineered blood vessel implant designed for trauma patients requiring urgent revascularization. Symvess offers a safer alternative to traditional vein harvesting or synthetic grafts, restoring blood flow and preserving limbs after severe injuries.

In December 2024, GVS S.p.A., an Italy-based plastic fabrication company, acquired blood-related assets from Haemonetics Corporation for $67.1 million. This acquisition strengthens GVS's focus on plasma and hospital-based blood management solutions while expanding its product offerings in the blood collection and filtration market. Haemonetics Corporation, a US-based company, specializes in developing and selling blood management devices, including artificial blood substitutes and other blood-related products.

Major players in the synthetic blood substitutes and blood products market are Takeda Pharmaceutical Company Limited, Fresenius Kabi AG, Baxter International Inc., Octapharma AG, Green Cross Corporation, Alliance Pharmaceutical Corporation, Hemosol Inc., Sanguine Corporation, Sangart Inc., Biopure Corporation, Tenex Therapeutics, Velico Medical, Hemarina S.A., KaloCyte Inc., Aurum Biosciences Limited, SpheriTech Limited, Dendritech Inc., HbO2 Therapeutics LLC, HemoBioTech Inc., Somatogen Inc.

North America was the largest region in the synthetic blood substitutes and blood products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in synthetic blood substitutes and blood products report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the synthetic blood substitutes and blood products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The synthetic blood substitutes and blood products market consists of sales of artificial blood substitutes, blood plasma substitutes, and blood plasma products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Synthetic Blood Substitutes And Blood Products Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on synthetic blood substitutes and blood products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for synthetic blood substitutes and blood products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The synthetic blood substitutes and blood products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Perfluorocarbon Based Product (PFC); Haemoglobin Based Oxygen Carrier; Synthetic Platelet; Recombinant Factor; Blood Expander
2) By Application: Cardiovascular Diseases; Anaemia; Organ Transplant; Injury and Trauma; Other Applications
3) By End-User: Hospitals And Clinics; Blood Banks; Other End users
Subsegments:
1) By Perfluorocarbon Based Product (PFC): Emulsion-Based Products; Non-Emulsion-Based Products
2) By Haemoglobin Based Oxygen Carrier: Polymerized Hemoglobin-Based Products; Crosslinked Hemoglobin-Based Products
3) By Synthetic Platelet: Platelet Substitutes; Platelet Aggregation Inhibitors
4) By Recombinant Factor: Recombinant Factor VIII; Recombinant Factor IX; Other Recombinant Factors
5) By Blood Expander: Colloid Solutions; Crystalloid Solutions
Companies Mentioned: Takeda Pharmaceutical Company Limited; Fresenius Kabi AG; Baxter International Inc.; Octapharma AG; Green Cross Corporation; Alliance Pharmaceutical Corporation; Hemosol Inc.; Sanguine Corporation; Sangart Inc.; Biopure Corporation; Tenex Therapeutics; Velico Medical; Hemarina S.A.; KaloCyte Inc.; Aurum Biosciences Limited; SpheriTech Limited; Dendritech Inc.; HbO2 Therapeutics LLC; HemoBioTech Inc.; Somatogen Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r34160u

1. Executive Summary

2. Synthetic Blood Substitutes And Blood Products Market Characteristics

3. Synthetic Blood Substitutes And Blood Products Market Trends And Strategies

4. Synthetic Blood Substitutes And Blood Products Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Synthetic Blood Substitutes And Blood Products Growth Analysis And Strategic Analysis Framework

5.1. Global Synthetic Blood Substitutes And Blood Products PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Synthetic Blood Substitutes And Blood Products Market Growth Rate Analysis
5.4. Global Synthetic Blood Substitutes And Blood Products Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Synthetic Blood Substitutes And Blood Products Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Synthetic Blood Substitutes And Blood Products Total Addressable Market (TAM)

6. Synthetic Blood Substitutes And Blood Products Market Segmentation

6.1. Global Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Perfluorocarbon Based Product (PFC)
Haemoglobin Based Oxygen Carrier
Synthetic Platelet
Recombinant Factor
Blood Expander
6.2. Global Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiovascular Diseases
Anaemia
Organ Transplant
Injury and Trauma
Other Applications
6.3. Global Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Blood Banks
Other End users
6.4. Global Synthetic Blood Substitutes And Blood Products Market, Sub-Segmentation Of Perfluorocarbon Based Product (PFC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Emulsion-Based Products
Non-Emulsion-Based Products
6.5. Global Synthetic Blood Substitutes And Blood Products Market, Sub-Segmentation Of Haemoglobin Based Oxygen Carrier, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerized Hemoglobin-Based Products
Crosslinked Hemoglobin-Based Products
6.6. Global Synthetic Blood Substitutes And Blood Products Market, Sub-Segmentation Of Synthetic Platelet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Platelet Substitutes
Platelet Aggregation Inhibitors
6.7. Global Synthetic Blood Substitutes And Blood Products Market, Sub-Segmentation Of Recombinant Factor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Factor VIII
Recombinant Factor IX
Other Recombinant Factors
6.8. Global Synthetic Blood Substitutes And Blood Products Market, Sub-Segmentation Of Blood Expander, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Colloid Solutions
Crystalloid Solutions

7. Synthetic Blood Substitutes And Blood Products Market Regional And Country Analysis

7.1. Global Synthetic Blood Substitutes And Blood Products Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Synthetic Blood Substitutes And Blood Products Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Synthetic Blood Substitutes And Blood Products Market

8.1. Asia-Pacific Synthetic Blood Substitutes And Blood Products Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Synthetic Blood Substitutes And Blood Products Market

9.1. China Synthetic Blood Substitutes And Blood Products Market Overview
9.2. China Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Synthetic Blood Substitutes And Blood Products Market

10.1. India Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Synthetic Blood Substitutes And Blood Products Market

11.1. Japan Synthetic Blood Substitutes And Blood Products Market Overview
11.2. Japan Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Synthetic Blood Substitutes And Blood Products Market

12.1. Australia Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Synthetic Blood Substitutes And Blood Products Market

13.1. Indonesia Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Synthetic Blood Substitutes And Blood Products Market

14.1. South Korea Synthetic Blood Substitutes And Blood Products Market Overview
14.2. South Korea Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Synthetic Blood Substitutes And Blood Products Market

15.1. Western Europe Synthetic Blood Substitutes And Blood Products Market Overview
15.2. Western Europe Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Synthetic Blood Substitutes And Blood Products Market

16.1. UK Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Synthetic Blood Substitutes And Blood Products Market

17.1. Germany Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Synthetic Blood Substitutes And Blood Products Market

18.1. France Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Synthetic Blood Substitutes And Blood Products Market

19.1. Italy Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Synthetic Blood Substitutes And Blood Products Market

20.1. Spain Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Synthetic Blood Substitutes And Blood Products Market

21.1. Eastern Europe Synthetic Blood Substitutes And Blood Products Market Overview
21.2. Eastern Europe Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Synthetic Blood Substitutes And Blood Products Market

22.1. Russia Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Synthetic Blood Substitutes And Blood Products Market

23.1. North America Synthetic Blood Substitutes And Blood Products Market Overview
23.2. North America Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Synthetic Blood Substitutes And Blood Products Market

24.1. USA Synthetic Blood Substitutes And Blood Products Market Overview
24.2. USA Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Synthetic Blood Substitutes And Blood Products Market

25.1. Canada Synthetic Blood Substitutes And Blood Products Market Overview
25.2. Canada Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Synthetic Blood Substitutes And Blood Products Market

26.1. South America Synthetic Blood Substitutes And Blood Products Market Overview
26.2. South America Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Synthetic Blood Substitutes And Blood Products Market

27.1. Brazil Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Synthetic Blood Substitutes And Blood Products Market

28.1. Middle East Synthetic Blood Substitutes And Blood Products Market Overview
28.2. Middle East Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Synthetic Blood Substitutes And Blood Products Market

29.1. Africa Synthetic Blood Substitutes And Blood Products Market Overview
29.2. Africa Synthetic Blood Substitutes And Blood Products Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Synthetic Blood Substitutes And Blood Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Synthetic Blood Substitutes And Blood Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Synthetic Blood Substitutes And Blood Products Market Competitive Landscape And Company Profiles

30.1. Synthetic Blood Substitutes And Blood Products Market Competitive Landscape
30.2. Synthetic Blood Substitutes And Blood Products Market Company Profiles
- 30.2.1. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Octapharma AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Green Cross Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Synthetic Blood Substitutes And Blood Products Market Other Major And Innovative Companies

31.1. Alliance Pharmaceutical Corporation
31.2. Hemosol Inc.
31.3. Sanguine Corporation
31.4. Sangart Inc.
31.5. Biopure Corporation
31.6. Tenex Therapeutics
31.7. Velico Medical
31.8. Hemarina S.A.
31.9. KaloCyte Inc.
31.10. Aurum Biosciences Limited
31.11. SpheriTech Limited
31.12. Dendritech Inc.
31.13. HbO2 Therapeutics LLC
31.14. HemoBioTech Inc.
31.15. Somatogen Inc.

32. Global Synthetic Blood Substitutes And Blood Products Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Synthetic Blood Substitutes And Blood Products Market

34. Recent Developments In The Synthetic Blood Substitutes And Blood Products Market

35. Synthetic Blood Substitutes And Blood Products Market High Potential Countries, Segments and Strategies

35.1 Synthetic Blood Substitutes And Blood Products Market In 2029 - Countries Offering Most New Opportunities
35.2 Synthetic Blood Substitutes And Blood Products Market In 2029 - Segments Offering Most New Opportunities
35.3 Synthetic Blood Substitutes And Blood Products Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer